An Australian study suggests a supervised food challenge may be the best way to diagnose peanut allergy in young children.

Dyve Biosciences targets acidic microenvironments in cancer and inflammatory conditions through transdermal delivery.

Europe has world-class biotech research, but can it scale? Nordic Life Science Days explores the capital, expertise, and ...

Phase III findings suggest a promising option for women whose endometrial cancer progresses despite prior chemotherapy and ...

Five-year trial results support chemotherapy de-escalation in HER2-positive breast cancer, with ctDNA offering additional ...

Encoded Therapeutics reports promising early Phase I/II results for its AAV gene therapy developed to treat children with ...

Researchers have developed an AI-powered personal health agent created as an open-source multi-agent framework for dynamic, personalized health interactions.

Researchers identify a genetic vulnerability that could enable safer WNT-targeted cancer therapies while sparing healthy cells.

Cervical cancer rates and deaths are increasing around the world, with the highest rates in sub-Saharan Africa.

New research identifies molecular signatures in SCLC that could improve immunotherapy outcome prediction beyond conventional staging.

Genetic differences impact immune cells and may pave the way to new precision medicines for conditions as diverse as multiple ...

A 12-year study of more than 52,000 women finds no increased cardiovascular risk with modern hormone replacement therapy started during midlife.